A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD
暂无分享,去创建一个
Charles T. Hindmarch | P. James | N. Renwick | Lisa Thibeault | J. Grabell | M. Bowman | K. Tyryshkin | P. Lima | Matteo Zago-Schmitt | Robbie Kloosterman
[1] A. Iorio,et al. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells , 2022, Journal of thrombosis and haemostasis : JTH.
[2] J. Di Paola,et al. Single Cell Transcriptional Analysis of Human Endothelial Colony Forming Cells from Patients with Low VWF Levels. , 2022, Blood.
[3] Yuqin Fan,et al. Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma , 2021, Cancer cell international.
[4] R. Mustafa,et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. , 2021, Blood advances.
[5] R. Mustafa,et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. , 2021, Blood advances.
[6] E. Weijers,et al. Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease , 2020, Journal of thrombosis and haemostasis : JTH.
[7] Z. Sauna,et al. Role of microRNAs in Hemophilia and Thrombosis in Humans , 2020, International journal of molecular sciences.
[8] J. Eikenboom,et al. von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD. , 2019, Blood advances.
[9] T. Tuschl,et al. Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing. , 2019, Endocrine-related cancer.
[10] A. Koster,et al. Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[11] S. Archer,et al. Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[12] C. Graham,et al. Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance , 2017, Oncotarget.
[13] D. Cutler,et al. von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. , 2016, Blood.
[14] Måns Magnusson,et al. MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..
[15] D. Bellissimo,et al. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. , 2016, Blood.
[16] R. Bierings,et al. Interaction between MyRIP and the actin cytoskeleton regulates Weibel–Palade body trafficking and exocytosis , 2016, Journal of Cell Science.
[17] Roland Eils,et al. circlize implements and enhances circular visualization in R , 2014, Bioinform..
[18] Paul Theodor Pyl,et al. HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[19] M. Periyasamy,et al. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts , 2013, Nucleic acids research.
[20] P. Reitsma,et al. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. , 2013, Blood.
[21] R. Dahiya,et al. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. , 2012, Cancer research.
[22] Thomas Tuschl,et al. Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing. , 2012, Methods.
[23] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[24] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[25] Changhong Sun,et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. , 2011, Nature communications.
[26] P. James,et al. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population , 2010, Pediatric blood & cancer.
[27] P. James,et al. The prevalence of symptomatic von Willebrand disease in primary care practice , 2010, Journal of thrombosis and haemostasis : JTH.
[28] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[29] P. Collins,et al. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease , 2006, Thrombosis and Haemostasis.
[30] P. Mannucci,et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.
[31] M. Rondaij,et al. Dynein-dynactin complex mediates protein kinase A-dependent clustering of Weibel-Palade bodies in endothelial cells. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[32] T. Podor,et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. , 2001, Blood.
[33] C. Wollheim,et al. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[34] L. Tsai,et al. ABO genotyping by mutagenically separated polymerase chain reaction. , 1996, Forensic science international.
[35] I. Macgregor,et al. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[36] E. Weibel,et al. NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA , 1964, The Journal of cell biology.
[37] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[38] L. O'Brien,et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. , 2007, Blood.
[39] J. Goudemand,et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). , 2007, Blood.
[40] C. Wollheim,et al. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. , 2000, The Journal of clinical investigation.
[41] F. Cohen,et al. Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.
[42] B. Binder,et al. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. , 1994, Acta haematologica Polonica.
[43] A. Venot,et al. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease. , 1992, Nouvelle revue francaise d'hematologie.